batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Bayer buys into NextRNA 28 August 2024 World Lung 2024 preview – the pressure is on for Summit 27 August 2024 Confirming Nuvation’s AnHeart takeover 22 August 2024 PTK7 seems key for Kelun 21 August 2024 Kineta is down, but not yet out 20 August 2024 Tissue factor tempts Adcendo 20 August 2024 J&J gets its first broad Rybrevant nod 20 August 2024 Dosing limit solves BioNTech's clinical hold 19 August 2024 Load More